Terms: = Endocrine gland cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Treatment
138 results:
1. Clinical and genetic analysis of a case of Gitelman syndrome accompanied with Graves disease and adrenocortical adenoma: A case report.
Qiao Y; Zhao J; Wu J; Cao L; Song G; Mao J
Medicine (Baltimore); 2024 Apr; 103(15):e37770. PubMed ID: 38608089
[TBL] [Abstract] [Full Text] [Related]
2. Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
Mehra T; Lupatsch JE; Kössler T; Dedes K; Siebenhüner AR; von Moos R; Wicki A; Schwenkglenks ME
PLoS One; 2024; 19(4):e0301271. PubMed ID: 38573891
[TBL] [Abstract] [Full Text] [Related]
3. Socioeconomic differences between medically and surgically treated prolactinomas: a retrospective review of 598 patients.
Osorio RC; Haddad AF; Hart DM; Goldrich N; Badani A; Kabir AS; Juncker R; Oh JY; Carrete L; Peeran Z; Chalif EJ; Zheng AC; Braunstein S; Theodosopoulos PV; El-Sayed IH; Gurrola J; Kunwar S; Blevins LS; Aghi MK
J Neurosurg; 2024 Mar; 140(3):712-723. PubMed ID: 37877974
[TBL] [Abstract] [Full Text] [Related]
4. Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network.
Jannin A; Giudici F; de la Fouchardière C; Al Ghuzlan A; Wassermann J; Chougnet CN; Drui D; Godbert Y; Ilouz F; Bardet S; Zanetta S; Roudaut N; Batisse Lignier M; Groussin L; Klein M; Zerdoud S; Lamartina L; Baudin E; Decaussin-Petrucci M; Leteurtre E; Borson Chazot F; Do Cao C; Borget I; Hadoux J;
Thyroid; 2023 Oct; 33(10):1190-1200. PubMed ID: 37855745
[No Abstract] [Full Text] [Related]
5. Analysis of the cost-effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan.
Hiroshima Y; Kondo M; Sawada T; Hoshi SL; Okubo R; Iizumi T; Numajiri H; Okumura T; Sakurai H
Cancer Med; 2023 Oct; 12(20):20450-20458. PubMed ID: 37795771
[TBL] [Abstract] [Full Text] [Related]
6. A putative role for ALDH inhibitors and chemoprevention of BRCA-mutation-driven tumors.
McGonigal S; Wu R; Grimley E; Turk EG; Zhai Y; Cho KR; Buckanovich RJ
Gynecol Oncol; 2023 Sep; 176():139-146. PubMed ID: 37535994
[TBL] [Abstract] [Full Text] [Related]
7. Validation of the KELIM score as a predictor of response to neoadjuvant treatment in patients with advanced high grade serous ovarian cancer.
Piedimonte S; Kim R; Bernardini MQ; Atenafu EG; Clark M; Lheureux S; May T
Gynecol Oncol; 2022 Dec; 167(3):417-422. PubMed ID: 37191644
[TBL] [Abstract] [Full Text] [Related]
8. An analysis of time to treatment in patients with pancreatic adenocarcinoma.
Sugumar K; Gendi S; Quereshy HA; Gupta S; Hue JJ; Rothermel LD; Ocuin LM; Ammori JB; Hardacre JM; Winter JM
Surgery; 2023 Jul; 174(1):83-90. PubMed ID: 37105784
[TBL] [Abstract] [Full Text] [Related]
9. Nanocurcumin preserves kidney function and haematology parameters in DMBA-induced ovarian cancer treated with cisplatin via its antioxidative and anti-inflammatory effect in rats.
Louisa M; Wanafri E; Arozal W; Sandhiutami NMD; Basalamah AM
Pharm Biol; 2023 Dec; 61(1):298-305. PubMed ID: 36708211
[TBL] [Abstract] [Full Text] [Related]
10. [Validation of calculation method for dose distribution around radioactive iodine-125 particles based on AAPM TG43 report].
Tian SQ; Wang JJ; Ji Z; Jiang YL; Qiu B; Fan JH; Sun HT
Zhonghua Yi Xue Za Zhi; 2023 Jan; 103(3):199-204. PubMed ID: 36649991
[No Abstract] [Full Text] [Related]
11. PD-L1 is highly expressed in ovarian cancer and associated with cancer stem cells populations expressing CD44 and other stem cell markers.
Alwosaibai K; Aalmri S; Mashhour M; Ghandorah S; Alshangiti A; Azam F; Selwi W; Gharaibeh L; Alatawi Y; Alruwaii Z; Alsaab HO
BMC Cancer; 2023 Jan; 23(1):13. PubMed ID: 36604635
[TBL] [Abstract] [Full Text] [Related]
12. Frequency of thoracic recurrence based on pathological features in patients with ovarian epithelial tumors in stage I versus higher stages.
Matsutani H; Nakai G; Fujiwara S; Takahashi S; Yamamoto K; Ohmichi M; Osuga K
Jpn J Radiol; 2023 May; 41(5):500-509. PubMed ID: 36575285
[TBL] [Abstract] [Full Text] [Related]
13. [Association of extranodal extension and lymph node ratio with radioactive iodine-refractory papillary thyroid cancer].
Luo ZY; Qin JW; Fang JG; Zheng C; Gong WB; Hei H
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3856-3861. PubMed ID: 36540923
[No Abstract] [Full Text] [Related]
14. Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma.
Tong Y; Sun M; Chen L; Wang Y; Li Y; Li L; Zhang X; Cai Y; Qie J; Pang Y; Xu Z; Zhao J; Zhang X; Liu Y; Tian S; Qin Z; Feng J; Zhang F; Zhu J; Xu Y; Lou W; Ji Y; Zhao J; He F; Hou Y; Ding C
J Hematol Oncol; 2022 Nov; 15(1):168. PubMed ID: 36434634
[TBL] [Abstract] [Full Text] [Related]
15. Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some cancers in Patients With Diabetes.
Na Y; Kim SW; Park IB; Choi SJ; Nam S; Jung J; Lee DH
J Clin Endocrinol Metab; 2022 Nov; 107(11):3022-3034. PubMed ID: 36108097
[TBL] [Abstract] [Full Text] [Related]
16. Oncologic management of ampullary cancer: International survey among surgical and medical oncologists.
de Jong EJM; Lemmers DHL; Benedetti Cacciaguerra A; Bouwense SAW; Geurts SME; Tjan-Heijnen VCG; Valkenburg-van Iersel LBJ; Wilmink JW; Besselink MG; Abu Hilal M; de Vos-Geelen J
Surg Oncol; 2022 Sep; 44():101841. PubMed ID: 36087543
[TBL] [Abstract] [Full Text] [Related]
17. MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions.
Prinz C; Fehring L; Frese R
Cells; 2022 Aug; 11(15):. PubMed ID: 35954223
[TBL] [Abstract] [Full Text] [Related]
18. Key factors for effective mitotane therapy in children with adrenocortical carcinoma.
Kuhlen M; Mier P; Kunstreich M; Lessel L; Schneider D; Brecht I; Schewe DM; Frühwald MC; Vorwerk P; Redlich A
Endocr Relat Cancer; 2022 Sep; 29(9):545-555. PubMed ID: 35900840
[TBL] [Abstract] [Full Text] [Related]
19. [Retrospective analysis of low-risk differentiated thyroid tumours: is lobectomy the adequate approach?].
Kovács GL; Hella Z; Vass L; Csapó Z
Orv Hetil; 2022 Jul; 163(27):1074-1081. PubMed ID: 35895468
[TBL] [Abstract] [Full Text] [Related]
20. Robotic versus open pancreaticoduodenectomy for distal cholangiocarcinoma: a multicenter propensity score-matched study.
Xu S; Zhang XP; Zhao GD; Zou WB; Zhao ZM; Hu MG; Gao YX; Tan XL; Liu Q; Liu R
Surg Endosc; 2022 Nov; 36(11):8237-8248. PubMed ID: 35534733
[TBL] [Abstract] [Full Text] [Related]
[Next]
